Superiority of high-dose over intermediate-dose cytosine arabinoside in the treatment of patients with high-risk acute myeloid leukemia: results of an age-adjusted prospective randomized comparison
Autor/innen
- W. Kern
- C. Aul
- G. Maschmeyer
- R. Schoenrock-Nabulsi
- W.D. Ludwig
- A. Bartholomaeus
- P. Bettelheim
- B. Woermann
- T. Buechner
- W. Hiddemann
Journal
- Leukemia
Quellenangabe
- Leukemia 12: 1049-1055